Free Trial

Rani Therapeutics (RANI) Institutional Ownership

Rani Therapeutics logo
$1.11 +0.06 (+5.71%)
Closing price 04:00 PM Eastern
Extended Trading
$1.11 0.00 (0.00%)
As of 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Rani Therapeutics (NASDAQ:RANI)

Current
Institutional Ownership
Percentage
30.19%
Number of
Institutional Buyers
(last 12 months)
21
Total
Institutional Inflows
(last 12 months)
$36.77M
Number of
Institutional Sellers
(last 12 months)
0
Get RANI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rani Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RANI Institutional Buying and Selling by Quarter

Rani Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/20/2026 Kestra Private Wealth Services LLC265,159$195K0.0%+4.1%0.214%
2/23/2026Virtu Financial LLC51,178$69K0.0%N/A0.042%
2/18/2026Millennium Management LLC163,300$220K0.0%N/A0.134%
2/18/2026Bridgeway Capital Management LLC114,500$155K0.0%N/A0.094%
2/18/2026683 Capital Management LLC487,168$658K0.0%N/A0.401%
2/17/2026RA Capital Management L.P.8,500,000$11.48M0.1%N/A6.995%
2/17/2026Farallon Capital Management LLC78,000$105K0.0%N/A0.064%
2/16/2026Squarepoint Ops LLC344,378$465K0.0%N/A0.283%
2/16/2026OMERS ADMINISTRATION Corp69,200$93K0.0%N/A0.057%
2/13/2026AWM Investment Company Inc.6,500,000$8.78M0.8%N/A5.349%
2/13/2026Siren L.L.C.2,000,000$2.70M0.1%N/A1.646%
2/13/2026State Street Corp387,042$523K0.0%+519.8%0.319%
2/12/2026 SymBiosis Capital Partners LLC6,300,000$8.51M8.2%N/A5.185%
2/10/2026Goldman Sachs Group Inc.285,832$386K0.0%N/A0.235%
2/9/2026Geode Capital Management LLC860,941$1.16M0.0%+190.0%0.709%
2/9/2026Jefferies Financial Group Inc.29,870$40K0.0%N/A0.025%
1/29/2026 Kestra Private Wealth Services LLC254,812$344K0.0%+12.7%0.210%
11/17/2025 Kestra Private Wealth Services LLC226,142$113K0.0%+44.8%0.186%
11/17/2025Citadel Advisors LLC452,542$226K0.0%+199.0%0.372%
10/22/2025 CWA Asset Management Group LLC150,000$75K0.0%+80.0%0.209%
8/14/2025Armistice Capital LLC3,151,354$1.62M0.0%N/A4.986%
7/17/2025 Janney Montgomery Scott LLC55,200$28K0.0%+102.9%0.087%
7/15/2025 Well Done LLC52,014$27K0.0%N/A0.090%
5/12/2025King Luther Capital Management Corp58,000$73K0.0%+75.8%0.101%
5/5/2025Kestra Private Wealth Services LLC139,156$175K0.0%+16.3%0.242%
4/21/2025CWA Asset Management Group LLC83,333$105K0.0%N/A0.145%
2/17/2025Two Sigma Advisers LP110,163$151K0.0%N/A0.192%
2/17/2025Two Sigma Investments LP291,381$399K0.0%N/A0.509%
2/17/2025Bridgeway Capital Management LLC56,500$77K0.0%-21.0%0.099%
2/13/2025Insigneo Advisory Services LLC47,500$65K0.0%N/A0.083%
2/12/2025Takeda Pharmaceutical Co. Ltd.203,190$278K1.0%N/A0.355%
2/11/2025Virtu Financial LLC45,404$62K0.0%N/A0.079%
2/7/2025King Luther Capital Management Corp33,000$45K0.0%-59.3%0.058%
1/17/2025Janney Montgomery Scott LLC27,200$37K0.0%N/A0.047%
11/16/2024Geode Capital Management LLC172,261$372K0.0%+14.3%0.323%
11/15/2024United Services Automobile Association302,743$654K0.0%-3.0%0.567%
11/15/2024Stifel Financial Corp269,768$583K0.0%+100.4%0.505%
11/8/2024King Luther Capital Management Corp81,129$175K0.0%+44.5%0.152%
8/14/2024Marshall Wace LLP21,247$81K0.0%N/A0.042%
8/9/2024Renaissance Technologies LLC21,700$82K0.0%-69.1%0.043%
Peptide Company Lands Exclusive MMA Wellness Partnership (Ad)

A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel

Read the full report on this small-cap peptide company now
8/7/2024United Services Automobile Association312,095$1.19M0.0%-35.2%0.619%
5/10/2024Vanguard Group Inc.685,303$2.13M0.0%+2.5%1.366%
2/14/2024Alpha Square Group S LLC58,946$196K0.2%-32.2%0.118%
8/10/2023King Luther Capital Management Corp56,129$231K0.0%N/A0.113%
8/4/2023Choreo LLC19,813$82K0.0%-20.2%0.040%
5/11/2023Icon Wealth Partners LLC12,757$66K0.0%N/A0.026%
5/11/2023Alphabet Inc.448,492$2.31M0.1%-12.1%0.908%
2/8/2023Prime Capital Investment Advisors LLC33,502$198K0.0%N/A0.068%
11/18/2022TPB Wealth Advisors48,129$461K0.2%-33.0%0.098%
11/16/2022Alphabet Inc.714,471$6.85M0.3%N/A1.453%
11/3/2022Motco48,129$461K0.0%N/A0.098%
10/28/2022Lafayette Investments Inc.19,893$191K0.1%N/A0.040%
10/17/2022Canton Hathaway LLC16,200$155K0.1%+88.4%0.033%
10/14/2022Iowa State Bank18,862$181K0.1%N/A0.038%
8/8/2022Islay Capital Management LLC9,611$99K0.1%N/A0.020%
8/8/2022Crossvault Capital Management LLC14,285$148K0.1%N/A0.029%
7/29/2022Aspireon Wealth Advisors71,811$742K0.3%N/A0.146%
7/20/2022Canton Hathaway LLC8,600$89K0.0%N/A0.017%
6/15/2022Lasry Marc62,828$848K0.4%N/A0.128%
5/17/2022Lasry Marc62,828$848K0.4%N/A0.128%
5/13/2022United Services Automobile Association481,300$6.50M0.1%N/A0.979%
2/3/2022Advisor Group Holdings Inc.21,072$344K0.0%N/A0.043%


RANI Institutional Ownership - Frequently Asked Questions

During the previous two years, 30 institutional investors and hedge funds held shares of Rani Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($11.48M), AWM Investment Company Inc. ($8.78M), SymBiosis Capital Partners LLC ($8.51M), Siren L.L.C. ($2.70M), Armistice Capital LLC ($1.62M), Geode Capital Management LLC ($1.16M), and 683 Capital Management LLC ($658K).Learn more on Rani Therapeutics' institutional investors.

30.19% of Rani Therapeutics' stock is owned by institutional investors. Learn more on RANI's institutional investor holdings.

Of the 28 institutional investors that purchased Rani Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($8.50M), AWM Investment Company Inc. ($6.50M), SymBiosis Capital Partners LLC ($6.30M), Armistice Capital LLC ($3.15M), Siren L.L.C. ($2M), Geode Capital Management LLC ($585.56K), and 683 Capital Management LLC ($487.17K).

Institutional investors have bought a total of 29,520,304 shares in the last 24 months. This purchase volume represents approximately $36.77M in transactions.



This page (NASDAQ:RANI) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners